BioNTech, the co-producer of Pfizer’s Covid-19 vaccine, boosted the 2021 delivery target for their product to 2 billion doses, up from 1,3 billion previously as they bring new production lines on stream and as more doses can be extracted per vial.
Brazil will soon weigh emergency-use approval for AstraZeneca's COVID-19 vaccine after Britain gave the green light on Wednesday, as Latin America's largest country rushes to catch up with immunization programs under way around the hard-hit region.
Pfizer has postponed the delivery of new batches of its coronavirus vaccine to eight European nations including Spain, the Spanish health ministry said on Monday, a day after the European Union began its immunization campaign.
Europe launched a mass Covid-19 vaccination drive on Sunday with pensioners and medics lining up to get the first shots to see off a pandemic that has crippled economies and claimed more than 1.7 million lives worldwide.
Argentina's medicine and food regulator extended on Tuesday an emergency use for the Pfizer/BioNtech vaccine in the country. These vaccines are expected to arrive in Argentina sometime between January and March.
United States president-elect Joe Biden received his first injected doses of the Covid-19 vaccine on live on television on Monday in an effort to boost confidence in its safety ahead of its wide distribution next year.
Moderna Inc's coronavirus vaccine on Friday became the second to receive emergency use authorization (EUA) from the U.S. Food and Drug Administration, welcome news to a nation with a staggering COVID-19 death toll of over 307,000 lives lost.
U.S. drugmaker Pfizer complained of a breach of confidentiality after a politician in Belgium published on Thursday the price per dose of COVID-19 vaccines ordered by the country, according to a Belgian newspaper.
Beginning 27 December people across the European Union will be able to get vaccinated against COVID-19, European Commission President Ursula von der Leven announced on Thursday.
The government of President Jair Bolsonaro said that Brazil has guaranteed access to 300 million vaccines, mainly those developed by Oxford University along with AstraZeneca pharmaceutical and Brazil's Fiocruz foundation, as well as vaccines from the Covax Facility international initiative.